Miromatrix Medical Inc.
MIRO · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $36 | $48 | $38 | $63 |
| - Cash | $6 | $5 | $14 | $5 |
| + Debt | $3 | $3 | $3 | $4 |
| Enterprise Value | $33 | $46 | $28 | $61 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | 31.2% | 6.7% | -99.1% | – |
| Gross Profit | -$0 | -$0 | -$0 | $1 |
| % Margin | -1,018.5% | -1,367.7% | -1,466.2% | 86.6% |
| EBITDA | -$6 | -$6 | -$7 | -$7 |
| % Margin | -55,031.4% | -73,180.8% | -85,713.4% | -745.2% |
| Net Income | -$6 | -$7 | -$7 | -$7 |
| % Margin | -57,746% | -76,675.1% | -90,091.8% | -746.6% |
| EPS Diluted | -0.24 | -0.24 | -0.32 | -0.33 |
| % Growth | 0% | 25% | 3% | – |
| Operating Cash Flow | -$5 | -$5 | -$9 | -$6 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$5 | -$5 | -$9 | -$6 |